Montillo, M., Tedeschi, A., Gaidano, G., Coscia, M., Petrizzi, V. B., Orlandi, E., . . . Massaia, M. (2014). Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients. Haematologica.
Citação norma ChicagoMontillo, Marco, et al. "Bendamustine and Subcutaneous Alemtuzumab Combination Is an Effective Treatment in Relapsed/refractory Chronic Lymphocytic Leukemia Patients." Haematologica 2014.
Citação norma MLAMontillo, Marco, et al. "Bendamustine and Subcutaneous Alemtuzumab Combination Is an Effective Treatment in Relapsed/refractory Chronic Lymphocytic Leukemia Patients." Haematologica 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.